Diagnosing brain tumors with a blood test
TORONTO - A simple but highly sensitive blood test has been found to accurately diagnose and classify different types of brain tumours, resulting in more accurate diagnosis, less invasive methods and better treatment planning for patients, in the future.
The finding, published in Nature Medicine on June 22, 2020, describes a non-invasive and easy way to classify brain tumours. The study is also being presented virtually today at the prestigious Opening Plenary Session of the American Association for Cancer Research Annual Meeting 2020: Turning Science into Lifesaving Care.
A major challenge in treating brain cancers is the accurate diagnosis of different types of brain cancers, and tumours ranging from low grade - which can look almost normal under a microscope - to aggressive tumours. Cancer grades are used to determine prognosis, and assist in treatment planning.
Current methods to diagnose and establish the subtype of brain cancer based on molecular information rely upon invasive surgical techniques to obtain tissue samples, which is a high-risk procedure and anxiety-provoking for patients.
The ability to diagnose and classify the type of brain tumour without the need for a tissue sample is revolutionary and practice changing. In some cases, surgery may not even be necessary.
"If we had a better and more reliable way to diagnose and subtype tumours, we could transform patient care," says Dr. Gelareh Zadeh, Medical Director of the Krembil Brain Institute, Head of Surgical Oncology at the Princess Margaret Cancer Centre, Senior Scientist at the Princess Margaret Cancer Research Institute, Professor of Surgery, University of Toronto, and a co-senior author in the study.
"It would have a tremendous impact on how we treat these cancers, and in how we plan our treatments."
Dr. Zadeh worked with Senior Scientist Dr. Daniel De Carvalho at Princess Margaret Cancer Centre, who is a world leader in the field of cancer epigenetics applied to early detection, classification and novel therapeutic interventions.
Dr. De Carvalho's lab specializes in a type of epigenetic modification called DNA methylation, which plays an important role in the regulation of gene expression (turning genes on or off) in cells. In cancer cells, DNA methylation patterns are disrupted, leading to unregulated cancer growth.
Dr. De Carvalho has previously developed a DNA methylation-based liquid biopsy approach to profile hundreds of thousands of these epigenetic alterations in DNA molecules circulating in the blood. These fragments are called circulating tumour DNA or ctDNA. Combining this new technology with machine learning, his team was able to develop a highly sensitive and accurate test to detect and classify multiple solid tumours.
Working together, Drs. Zadeh and De Carvalho decided to use this same approach in the challenging application of intracranial brain tumour classification. The clinicians and scientists tracked the cancer origin and type by comparing patient tumour samples of brain cancer pathology, with the analysis of cell-free DNA circulating in the blood plasma from 221 patients.
Using this approach, they were able to match the circulating plasma ctDNA to the tumour DNA, confirming their ability to identify brain tumour DNA circulating in the blood of these patients. Then, using a machine learning approach, they developed a computer program to classify the brain tumour type based solely on the circulating tumour DNA.
Prior to this, it was not thought possible to detect any brain cancers with a blood test because of the impermeable blood-brain barrier, says Dr. Zadeh. This barrier exists between the brain's blood vessels and its tissue, protecting the brain from any toxins in the blood.
"But because this test is so sensitive in picking up even small amounts of highly specific tumour-derived signals in the blood, we now have a new, non-invasive way of detecting and discriminating between common brain tumours - something which was long thought impossible. This really is a tour de force," explains Dr. Zadeh.
Dr. Daniel De Carvalho, a Canada Research Chair in Cancer Epigenetics and Associate Professor at University of Toronto, adds that the field of identifying tumour-specific alterations in ctDNA with new, more sensitive tests in various body fluids - such as blood and urine - is now at a turning point because advanced technologies can detect and analyze even the smallest traces of cancer-specific molecular signatures from the vast quantities of circulating non-tumour DNA fragments.
"The possibility to map epigenetic modifications genome-wide, combined with powerful computational approaches, has brought us to this tipping point," says Dr. De Carvalho.
"Molecular characterization of tumours by profiling epigenetic alterations in addition to genetic mutations gives us a more comprehensive understanding of the altered features of a tumour, and opens the possibilities for more specific, sensitive, and tumour agnostic tests."
In an accompanying paper, also published in Nature Medicine on June 22, 2020, Dr. Carvalho and his collaborators from the Dana-Farber Cancer Institute at Harvard University show the same blood test can accurately identify kidney cancer from circulating cell-free DNA obtained either from plasma or from urine.
###
Contributing to the study on diagnosing and classifying brain tumours are lead authors: Farshad Nassiri, Vanier Canada Graduate Scholar, Ankur Chakravarthy, Banting Postdoctoral Fellow, and Shengrui Feng. Additional authors include: Shu Yi Shen, Romina Nejad, Jeffrey Zuccato, Mathew R. Voisin, Vikas Patil, Craig Horbinski, Kenneth Aldape, and senior authors Drs. Gelareh Zadeh and Daniel De Carvalho.
Dr. Daniel De Carvalho, Shu Yi Shen and Dr. Ankur Chakravarthy are listed as inventors on patents filed that are related to this method.
Funding for the research includes: Canadian Institutes of Health Research, Brain Tumour Charity UK Quest for Cures, Princess Margaret Cancer Foundation, Toronto General & Western Hospital Foundation, Natural Sciences and Engineering Research Council of Canada and Ontario Institute for Cancer Research.
About Princess Margaret Cancer Centre
Princess Margaret Cancer Centre has achieved an international reputation as a global leader in the fight against cancer and delivering personalized cancer medicine. The Princess Margaret, one of the top five international cancer research centres, is a member of the University Health Network, which also includes Toronto General Hospital, Toronto Western Hospital, Toronto Rehabilitation Institute and the Michener Institute for Education at UHN. All are research hospitals affiliated with the University of Toronto. For more information: http://www.theprincessmargaret.ca
About Krembil Brain Institute
Krembil Brain Institute at Toronto Western Hospital is home to one of the world's largest and most comprehensive teams of physicians and scientists uniquely working hand-in-hand to prevent and confront problems of the brain and spine. One in three Canadians will experience a brain-related condition such as Parkinson's, Alzheimer's or stroke in their lifetime. Through state-of-the-art patient care and advanced research, we are working relentlessly to find new treatments and cures. For more information: http://www.uhnresearch.ca/institutes/krembil
About University Health Network
University Health Network consists of Toronto General and Toronto Western Hospitals, the Princess Margaret Cancer Centre, Toronto Rehabilitation Institute, and The Michener Institute of Education at UHN. The scope of research and complexity of cases at University Health Network has made it a national and international source for discovery, education and patient care. It has the largest hospital-based research program in Canada, with major research in cardiology, transplantation, neurosciences, oncology, surgical innovation, infectious diseases, genomic medicine and rehabilitation medicine. University Health Network is a research hospital affiliated with the University of Toronto. For more information: http://www.uhn.ca
For media inquiries, please contact:
Alexandra Radkewycz Senior Public Affairs Advisor Princess Margaret Cancer Centre, University Health Network Phone: 416-946-2846 Email: Alexandra.Radkewycz@uhn.ca
Heather Sherman Senior Public Affairs Advisor Krembil Brain Institute, University Health Network Phone: 416-603-5294 Email: heather.sherman@uhn.ca
This story has been published on: 2020-06-22. To contact the author, please use the contact details within the article.
View post:
Diagnosing brain tumors with a blood test - 7thSpace Interactive
- Molecular Cardiology Research Lab - Texas Heart Institute - April 15th, 2018 [April 15th, 2018]
- Cardiology - Cardiologists - New York - Montefiore Medical ... - May 7th, 2018 [May 7th, 2018]
- PET/CT - Molecular Imaging - Nuclear MedicinePET-CTPET ... - May 26th, 2018 [May 26th, 2018]
- Molecular Cardiology Centenary Institute - July 16th, 2018 [July 16th, 2018]
- Pediatric Cardiology Fellowship | Pediatrics | University ... - September 25th, 2018 [September 25th, 2018]
- Molecular Multi - 3formulas.com - November 4th, 2018 [November 4th, 2018]
- Society of Nuclear Medicine and Molecular Imaging (SNMMI) - December 20th, 2018 [December 20th, 2018]
- Cardiology 2019 | Cardiology Conferences | Cardiology ... - February 5th, 2019 [February 5th, 2019]
- Cardiology | medicine | Britannica.com - March 18th, 2019 [March 18th, 2019]
- Cardiology | Baylor College of Medicine | Houston, Texas - April 12th, 2019 [April 12th, 2019]
- Cardiology Conferences | Cardiology Meetings | cardiology ... - September 11th, 2019 [September 11th, 2019]
- Nuclear Medicine/Radiopharmaceuticals Market Research Report by Key Players Analysis - Rapid News Network - September 21st, 2019 [September 21st, 2019]
- Macroscopic Imaging Market Growth with Worldwide Industry Analysis to 2019-2027 - Rapid News Network - September 21st, 2019 [September 21st, 2019]
- PET MRI Market to Record an Exponential CAGR by 2025 - Analytics News - September 21st, 2019 [September 21st, 2019]
- In Vitro Diagnostics/IVD Market Rapid Growth with Rising Application Scope by 2026 | Top Players- Danaher, Abbott, Thermo Fisher Scientific Inc,... - September 21st, 2019 [September 21st, 2019]
- Nuclear Imaging Devices Market Industry Outlook, Size, Share, Growth Prospects, Key Opportunities, Trends and Forecast - Wolf Mirror - September 21st, 2019 [September 21st, 2019]
- Heparin-induced Thrombocypenia Treatment Market Size & Share Expanding Across The Globe By 2018 2028 - NewsVarsity - September 21st, 2019 [September 21st, 2019]
- Medical Animation Market is Booming at a CAGR of 8.5% Due To Growing Demand By 2019 - 2026 - US Trade Media - September 21st, 2019 [September 21st, 2019]
- Molecular Imaging Market Will Make a Huge Impact in Near Future - Wolf Mirror - September 21st, 2019 [September 21st, 2019]
- FDA Clears ARTIS icono Family of Angiography Systems From Siemens Healthineers - BioSpace - September 21st, 2019 [September 21st, 2019]
- MR Solutions' liquid helium free PET-MR system firmly on the agenda at WMIC - DOTmed HealthCare Business News - September 21st, 2019 [September 21st, 2019]
- Molecular Imaging Devices Market Forecast to 2024 Explored in Latest Research - OnYourDesks - September 21st, 2019 [September 21st, 2019]
- Antibody Production Market Overview on Key Innovations 2023 - TodayTimes - September 24th, 2019 [September 24th, 2019]
- BRIC IVD Market Overview and Scope 2019 to 2024 | Key Players: Roche Diagnostics, Abbott Laboratories, Inc., & more Analytics News - Analytics... - September 24th, 2019 [September 24th, 2019]
- Best Report on Diagnostic Catheter Market 2026 with Major Eminent Key Players Biosense Webster, Inc, Medtronic plc, St. Jude Medical, Boston... - September 24th, 2019 [September 24th, 2019]
- Molecular Imaging Devices Market Industry Shares Report Analysis 2019-2027 - QbnNews - September 24th, 2019 [September 24th, 2019]
- Molecular Imaging Market value projected to expand by 2017 2027 - Analytics News - September 24th, 2019 [September 24th, 2019]
- ESMO Annual Meeting 2019: Menarini Ricerche Presents the Preclinical Characterization of MEN1611, a Novel PI3K Inhibitor in Development for the... - September 24th, 2019 [September 24th, 2019]
- Not for the faint-hearted: why some kids blackout playing video games - The Age - September 24th, 2019 [September 24th, 2019]
- Role of Machine Learning and AI in Precision Medicine - Healthcare Tech Outlook - October 11th, 2019 [October 11th, 2019]
- Here's Why Qiagen Plummeted Today - The Motley Fool - October 11th, 2019 [October 11th, 2019]
- Research Fellow in Muscle Biology job with UNIVERSITY OF LEEDS | 182894 - Times Higher Education (THE) - October 12th, 2019 [October 12th, 2019]
- Upregulation Of Renal GLUT2 And SGLT2 Is Involved In High-Fat Diet-Ind | DMSO - Dove Medical Press - October 17th, 2019 [October 17th, 2019]
- Contrasting of Merit Medical Systems Inc. (MMSI) and BioLife Solutions Inc. (NASDAQ:BLFS) - MS Wkly - October 18th, 2019 [October 18th, 2019]
- Unexpected Growth Seen in Radiopharmaceutical Market Global Forecast to 2025 with Key Players Bayer, Cardinal Health, GE Healthcare, ABT Molecular... - October 18th, 2019 [October 18th, 2019]
- No. 447: Thunderbolts and lasers, with Adelphi's all-world dean and the Father of Rock 'n Roll - Innovate Long Island - October 18th, 2019 [October 18th, 2019]
- Global Molecular Imaging Agents Market Report: Regional Data Analysis by Production, Revenue, Price and Gross Margin - Market Research Writeup - October 22nd, 2019 [October 22nd, 2019]
- Gene Therapy/Editing Series 1: A Brief Introduction To Gene Therapy - Seeking Alpha - October 29th, 2019 [October 29th, 2019]
- What are the Major Reasons for Rise in Molecular Imaging Market in Recent Period? - The Chicago Sentinel - October 29th, 2019 [October 29th, 2019]
- IVD Market insights size status gross margin and outlook 2019-2025 investigated in the latest research -... - WhaTech - October 30th, 2019 [October 30th, 2019]
- Radiopharmaceutical Market Size, Share 2019 - Growth Insight, Comprehensive Analysis, Top Leading Players, Future Demand and Forecast to 2023 -... - October 30th, 2019 [October 30th, 2019]
- This is the world's smallest commercially available sensor, and it really is tiny! - RedShark News - October 30th, 2019 [October 30th, 2019]
- New model of irregular heartbeat could boost drug efficacy | The Source - Washington University in St. Louis Newsroom - October 30th, 2019 [October 30th, 2019]
- Global In Vitro Diagnostics (IVD) Market Industry Analysis and Forecast (2018-2026) - Maxi Wire - November 7th, 2019 [November 7th, 2019]
- New Studies Demonstrate the Predictive Value of the Vectra Test in People Diagnosed with Rheumatoid Arthritis - GlobeNewswire - November 10th, 2019 [November 10th, 2019]
- BRIC IVD Market with Future Prospects, Key Player SWOT Analysis and Forecast To 2024 - Columnist 360 - December 2nd, 2019 [December 2nd, 2019]
- Global Molecular Imaging Agents Market: What it got next? Find out with the latest research available at 'The Market Reports' - Inquiry 24 - December 2nd, 2019 [December 2nd, 2019]
- Molecular Imaging Market to Witness CAGR of 7.5% Rise in Value Share During the Period 2017 2027 - chronicles24 - December 2nd, 2019 [December 2nd, 2019]
- Medical Imaging Equipment Market Global Industry Size, Revenue Growth Development, Business Opportunities, Future Trends, Top Key Players, Market... - December 12th, 2019 [December 12th, 2019]
- PhD Position in Molecular Medicine job with NORWEGIAN UNIVERSITY OF SCIENCE & TECHNOLOGY -NTNU | 188846 - Times Higher Education (THE) - December 12th, 2019 [December 12th, 2019]
- Miss America 2020: Here's a look at the 51 beautiful women who will be competing to take home the crown - MEAWW - December 18th, 2019 [December 18th, 2019]
- Vitro Diagnostics Market: Key Players and Production Information analysis with Forecast 2022 - Downey Magazine - December 18th, 2019 [December 18th, 2019]
- Famed Medical Researcher Partners with Center for Vein Restoration Dr. Armin Foghi - PR Web - December 18th, 2019 [December 18th, 2019]
- Human fat cells tweaked to function like a pacemaker - Times of India - December 18th, 2019 [December 18th, 2019]
- Human fat cells tweaked to work like hearts pacemaker: Study - BusinessLine - December 18th, 2019 [December 18th, 2019]
- Year in Review: Payment Fights, Wearables, Burnout Defined Cardiology Practice in 2019 - TCTMD - December 18th, 2019 [December 18th, 2019]
- Global Nuclear Imaging Equipment Market 2019-2023 | Evolving Opportunities With Canon Inc. and Mediso Ltd. | Technavio - Business Wire - January 12th, 2020 [January 12th, 2020]
- Isothermal Nucleic Acid Amplification Technology Market Worth $3.3 Billion in 2024 - Exclusive Report by MarketsandMarkets - PRNewswire - January 16th, 2020 [January 16th, 2020]
- No one knew why some Amish children were dying suddenly. Now researchers have some answers - The Albany Herald - January 16th, 2020 [January 16th, 2020]
- Quantum Genomics to Present at the Gordon Research Conference 2020 Dedicated to the Renin Angiotensin Aldosterone System - Yahoo Finance - January 16th, 2020 [January 16th, 2020]
- Mount Sinai Research Finds that Heterogeneity of Liver Cancer Cells Help Explain Tumor Progression in Patients - PR Web - January 20th, 2020 [January 20th, 2020]
- Medical Imaging Equipment Market Size 2020, Trends, Industry Share, Business Opportunities and Demand Forecast to 2025 - Medical Market News - January 31st, 2020 [January 31st, 2020]
- Invicro Scientists Work on Imaging Synaptic Density in Schizophrenia Published in Nature Communications - Yahoo Finance - January 31st, 2020 [January 31st, 2020]
- 2020 In Vitro Diagnostics (IVD) Market Report- Growth, Challenges, Attractive Valuation and Top Key Players - Science of Change - February 1st, 2020 [February 1st, 2020]
- IVD Market To Inspect Growth Trends during Forecast Period 2019 to 2026 |Siemens, Danaher Corporation, Becton - Expedition 99 - February 1st, 2020 [February 1st, 2020]
- Invicro Scientists Work on Imaging Synaptic Density in Schizophrenia Published in Nature Communications - Business Wire - February 1st, 2020 [February 1st, 2020]
- PET Radiopharmaceuticals Market Report (2019-2025) | The demand for the Market will drastically increase in the Future - Chronicle 99 - February 17th, 2020 [February 17th, 2020]
- In Vitro Diagnostics (IVD) and Laboratory Developed Tests for Autoimmune Diseases Market With Top Countries Data Analysis and Forecast 2025 by Recent... - February 17th, 2020 [February 17th, 2020]
- North American Nuclear Medicine Market Expected to Reach USD 2.7 Billion by 2024 with a CAGR of 4.1% - ResearchAndMarkets.com - Business Wire - February 17th, 2020 [February 17th, 2020]
- Biologic And Medical Imaging Reagents Market to Make Great Impact in near Future by -2022 - Kentucky Journal 24 - February 17th, 2020 [February 17th, 2020]
- Global In Vitro Diagnostics (IVD) Industry, Forecast to 2027 - Molecular Diagnostics to Exhibit the Fastest Growth - Yahoo Finance - March 8th, 2020 [March 8th, 2020]
- GeneDx Celebrates 20 Year History as Pioneer In Genetic Sequencing and Testing - BioBuzz - March 22nd, 2020 [March 22nd, 2020]
- Contract Development and Manufacturing Organization Market worth USD 278.98 Billion by 2026; Increasing Demand for Pharmaceutical Products Will Aid... - March 24th, 2020 [March 24th, 2020]
- Outlook into the Global Hybrid Imaging Market to 2025 - by Application, Type, End Use and Region - Yahoo Finance - March 24th, 2020 [March 24th, 2020]
- Smoking cessation counseling and e-cigs may be effective for breaking the habit - Mental Daily - April 1st, 2020 [April 1st, 2020]
- How daylight saving time affects health, and why Turkey was right to abandon it - Daily Sabah - April 1st, 2020 [April 1st, 2020]
- Single-Photon Emission Computed Tomography Market by Key Players, Regions, Type and Application, Forecast to 2027 - Jewish Life News - April 1st, 2020 [April 1st, 2020]
- Caravaggio Backs Apixaban for Prevention of VTE Recurrence in Cancer Patients - TCTMD - April 1st, 2020 [April 1st, 2020]
- In-Vitro Diagnostics Market 2020 | Top Business Growing Strategies, Technological Innovation and Emerging Trends of Outlook To 2028 - Publicist360 - April 10th, 2020 [April 10th, 2020]
- Abbott's Point-of-Care COVID-19 Test Delivers Results Within Minutes - The Cardiology Advisor - April 10th, 2020 [April 10th, 2020]